Gujarat-based manufacturer, trader and exporter of acid, basic, reactive, solvent and direct dyes and intermediates for the textile and paper industries.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 1 | 1 | 1 | 12 | 18 | 18 |
| Reserves | 4 | 6 | 10 | 5 | 30 | 31 |
| Borrowings | 10 | 13 | 13 | 15 | 18 | 22 |
| Other Liabilities | 20 | 18 | 20 | 30 | 26 | 20 |
| Total Liabilities | 34 | 39 | 45 | 61 | 91 | 90 |
| AssetsFixed Assets | 3 | 3 | 3 | 3 | 3 | 3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 30 | 35 | 41 | 57 | 87 | 86 |
| Total Assets | 34 | 39 | 45 | 61 | 91 | 90 |
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ActivitiesCash from Operating | — | — | 2 | 1 | -29 |
| Cash from Investing | — | — | 0 | -3 | 4 |
| Cash from Financing | — | — | -2 | 2 | 33 |
| SummaryCapital Expenditure | — | — | — | — | — |
| Free Cash Flow | — | — | 2 | 0 | -29 |
| FCF Margin | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (3.3×) and current (2.8×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 10% growth and a 3× exit, ₹16 only delivers your return if you pay ₹12. The price is currently baking in 16% growth.
EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 3×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 10.0% | 6.12 |
| FY28 | 10.0% | 6.73 |
| FY29 | 10.0% | 7.40 |
| FY30 | 10.0% | 8.14 |
| FY31 | 10.0% | 8.95 |
| FY32 | 8.0% ·fade | 9.67 |
| FY33 | 6.0% ·fade | 10.25 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.